Stryker Corporation (SYK) reported $26.30B of revenue for the twelve months ended Sep 30, 2026. That is up 7.9% from the year before. Revenue for fiscal 2025 was $25.12B.

Yes. Stryker Corporation earned $3.62B in net income for the twelve months ended Sep 30, 2026, a net margin of 13.8%.

How much cash and debt does SYK have?

Stryker Corporation reported $3.27B in cash and cash equivalents and $14.93B of debt on its most recent balance sheet in SEC filings.

How fast is SYK revenue growing?

Stryker Corporation's revenue changed +11.2% in fiscal 2025, to $25.12B. Its compound annual growth rate was +11.8% over 5 years and +9.7% over 10 years.

What is SYK gross margin?

Stryker Corporation's gross profit was $17.18B on $26.30B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 65.3%.

What is SYK free cash flow?

Stryker Corporation generated $4.57B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $5.45B less capital expenditures.

What is SYK earnings per share?

Diluted earnings per share were $9.39 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.

When did SYK last report financial results?

The latest statements here come from Stryker Corporation's 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.

Where does this SYK financial data come from?

Quantisnow builds these statements from the structured XBRL data Stryker Corporation files with the SEC. It is provided for information only and is not investment advice.

Financials · SYK

Stryker Corporation (SYK) financials

For the twelve months ended Sep 30, 2026, Stryker Corporation reported $26.30B of revenue and $3.62B of net income.

Revenue, TTM: $26.30B
Revenue growth, YoY: +7.9%
Net income, TTM: $3.62B
Net income growth, YoY: +23.1%
Net margin: 13.8%
Free cash flow, TTM: $4.57B
EPS, diluted, TTM: $9.39
EPS growth, YoY: +23.4%
Cash: $3.27B
Total debt: $14.93B
P/E: 33.50
P/S: 4.61
Market cap: $121.36B

Annual revenue$25.12B

FY2016FY2025

Annual net income$3.25B

FY2016FY2025

Annual free cash flow$4.28B

FY2016FY2025

SYK revenue and earnings growth

SYK revenueQ3 2026$6.52B

Quarter YoY: +7.6%
QoQ: -1.0%
FY YoY: +11.2%
5Y CAGR: +11.8%
10Y CAGR: +9.7%

SYK revenue was $6.52B in fiscal Q3 2026 (ended Sep 30, 2026), up 7.6% from a year earlier and down 1.0% from the prior quarter. For the full fiscal 2025 it was $25.12B, up 11.2% from fiscal 2024. Compound annual growth was +11.8% over 5 years and +9.7% over 10 years. It rose in 9 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

SYK net incomeQ3 2026$753.00M

Quarter YoY: -12.3%
QoQ: -41.0%
FY YoY: +8.5%
5Y CAGR: +15.2%
10Y CAGR: +8.5%

SYK net income was $753.00M in fiscal Q3 2026 (ended Sep 30, 2026), down 12.3% from a year earlier and down 41.0% from the prior quarter. For the full fiscal 2025 it was $3.25B, up 8.5% from fiscal 2024. Compound annual growth was +15.2% over 5 years and +8.5% over 10 years. It rose in 6 of the last 10 fiscal years.

SYK EPSQ3 2026$1.96

Quarter YoY: -11.7%
QoQ: -40.6%
FY YoY: +8.2%
5Y CAGR: +14.9%
10Y CAGR: +8.3%

SYK diluted EPS was $1.96 in fiscal Q3 2026 (ended Sep 30, 2026), down 11.7% from a year earlier and down 40.6% from the prior quarter. For the full fiscal 2025 it was $8.40, up 8.2% from fiscal 2024. Compound annual growth was +14.9% over 5 years and +8.3% over 10 years.

SYK free cash flowQ3 2026$1.22B

Quarter YoY: -9.5%
QoQ: +15.6%
FY YoY: +22.8%
5Y CAGR: +9.0%
10Y CAGR: +19.7%

SYK free cash flow was $1.22B in fiscal Q3 2026 (ended Sep 30, 2026), down 9.5% from a year earlier and up 15.6% from the prior quarter. For the full fiscal 2025 it was $4.28B, up 22.8% from fiscal 2024. Compound annual growth was +9.0% over 5 years and +19.7% over 10 years. It rose in 6 of the last 10 fiscal years. Fiscal 2025 is the highest of the 15 fiscal years on file.

Export CSV

Income statement

Income statement
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue	$25.12B	$22.59B	$20.50B	$18.45B	$17.11B	$14.35B	$14.88B	$13.60B	$12.44B	$11.32B
Cost of revenue	$9.05B	$8.15B	$7.44B	$6.87B	$6.14B	$5.29B	$5.19B	$4.66B	$4.26B	$3.82B
Gross profit	$16.07B	$14.44B	$13.06B	$11.58B	$10.97B	$9.06B	$9.70B	$8.94B	$8.18B	$7.50B
Research and development	$1.62B	$1.47B	$1.39B	$1.45B	$1.24B	$984.00M	$971.00M	$862.00M	$787.00M	$715.00M
Selling, general and admin	$8.65B	$7.68B	$7.11B	$6.39B	$6.43B	$5.36B	$5.36B	$5.10B	$4.55B	$4.14B
Operating income	$4.89B	$3.69B	$3.89B	$2.84B	$2.58B	$2.22B	$2.71B	$2.54B	$2.30B	$2.17B
Interest expense	$607.00M	$409.00M	$363.00M	-	-	-	-	-	-	-
Pre-tax income	$4.51B	$3.49B	$3.67B	$2.68B	$2.28B	$1.95B	$2.56B	$2.36B	$2.06B	$1.92B
Income tax	$1.27B	$499.00M	$508.00M	$325.00M	$287.00M	$355.00M	$479.00M	-$1.20B	$1.04B	$274.00M
Net income	$3.25B	$2.99B	$3.17B	$2.36B	$1.99B	$1.60B	$2.08B	$3.55B	$1.02B	$1.65B
EPS, basic	$8.49	$7.86	$8.34	$6.23	$5.29	$4.26	$5.57	$9.50	$2.73	$4.40
EPS, diluted	$8.40	$7.76	$8.25	$6.17	$5.21	$4.20	$5.48	$9.34	$2.68	$4.35
Diluted shares	386.5M	385.6M	383.7M	382.2M	382.3M	380.3M	379.9M	380.3M	380.1M	378.5M

Balance sheet

Balance sheet
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Cash and equivalents	$4.01B	$3.65B	$2.97B	$1.84B	$2.94B	$2.94B	$4.34B	$3.62B	$2.54B	$3.32B
Receivables	$4.04B	$3.99B	$3.77B	$3.56B	$3.02B	$2.70B	$2.89B	$2.33B	$2.20B	$1.97B
Inventory	$5.31B	$4.77B	$4.84B	$4.00B	$3.31B	$3.49B	$2.98B	$2.96B	$2.46B	$2.03B
Current assets	$14.76B	$14.85B	$12.52B	$10.28B	$10.02B	$9.71B	$11.06B	$9.73B	$7.99B	$7.86B
Goodwill	$19.29B	$15.86B	$15.24B	$14.88B	$12.92B	$12.78B	$9.07B	$8.56B	$7.17B	$6.36B
Total assets	$47.84B	$42.97B	$39.91B	$36.88B	$34.63B	$34.33B	$30.17B	$27.23B	$22.20B	$20.43B
Current liabilities	$7.79B	$7.62B	$7.92B	$6.30B	$4.55B	$5.04B	$4.40B	$4.81B	$3.48B	$3.15B
Short-term debt	$1.00B	$1.41B	$2.09B	$1.19B	$7.00M	$761.00M	$859.00M	$1.37B	$632.00M	$228.00M
Long-term debt	$14.86B	$12.19B	$10.90B	$11.86B	$12.47B	$13.23B	$10.23B	$8.49B	$6.59B	$6.69B
Total debt	$15.86B	$13.60B	$12.99B	$13.05B	$12.48B	$13.99B	$11.09B	$9.86B	$7.22B	$6.91B
Total liabilities	$25.42B	$22.34B	$21.32B	$20.27B	$19.75B	$21.25B	$17.36B	$15.50B	$12.22B	$10.88B
Shareholders' equity	$22.42B	$20.63B	$18.59B	$16.62B	$14.88B	$13.08B	$12.81B	$11.73B	$9.98B	$9.55B

Cash flow

Cash flow
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Operating cash flow	$5.04B	$4.24B	$3.71B	$2.62B	$3.26B	$3.28B	$2.19B	$2.61B	$1.56B	$1.92B
Capital expenditures	$761.00M	$755.00M	$575.00M	$588.00M	$525.00M	$487.00M	$649.00M	$572.00M	$598.00M	$490.00M
Free cash flow	$4.28B	$3.49B	$3.14B	$2.04B	$2.74B	$2.79B	$1.54B	$2.04B	$961.00M	$1.43B
Investing cash flow	-$4.87B	-$3.00B	-$962.00M	-$2.92B	-$859.00M	-$4.70B	-$1.46B	-$2.86B	-$1.61B	-$4.19B
Financing cash flow	$113.00M	-$525.00M	-$1.59B	-$749.00M	-$2.37B	-$11.00M	$3.00M	$1.33B	-$794.00M	$2.26B
Dividends paid	$1.28B	$1.22B	$1.14B	$1.05B	$950.00M	$863.00M	$778.00M	$703.00M	$636.00M	$568.00M
Share repurchases	-	-	-	-	$0	$0	$307.00M	$300.00M	$230.00M	$13.00M
Stock-based compensation	$243.00M	$229.00M	$205.00M	$168.00M	$171.00M	$142.00M	$127.00M	$119.00M	$113.00M	$97.00M
Depreciation and amortization	$1.57B	$1.43B	$1.34B	$1.28B	$1.27B	$1.08B	$1.04B	$966.00M	$859.00M	$752.00M

Key ratios

Key ratios
Line item	FY2025 Dec 31, 2025	FY2024 Dec 31, 2024	FY2023 Dec 31, 2023	FY2022 Dec 31, 2022	FY2021 Dec 31, 2021	FY2020 Dec 31, 2020	FY2019 Dec 31, 2019	FY2018 Dec 31, 2018	FY2017 Dec 31, 2017	FY2016 Dec 31, 2016
Revenue growth, YoY	11.2%	10.2%	11.1%	7.8%	19.2%	-3.6%	9.4%	9.3%	9.9%	13.9%
Net income growth, YoY	8.5%	-5.4%	34.2%	18.3%	24.7%	-23.2%	-41.4%	248.3%	-38.1%	14.5%
EPS growth, YoY	8.2%	-5.9%	33.7%	18.4%	24.0%	-23.4%	-41.3%	248.5%	-38.4%	15.1%
Gross margin	64.0%	63.9%	63.7%	62.8%	64.1%	63.1%	65.1%	65.7%	65.7%	66.3%
Operating margin	19.5%	16.3%	19.0%	15.4%	15.1%	15.5%	18.2%	18.7%	18.5%	19.2%
Net margin	12.9%	13.2%	15.4%	12.8%	11.7%	11.1%	14.0%	26.1%	8.2%	14.5%
Free cash flow margin	17.1%	15.4%	15.3%	11.0%	16.0%	19.4%	10.4%	15.0%	7.7%	12.6%
Return on equity	14.5%	14.5%	17.0%	14.2%	13.4%	12.2%	16.3%	30.3%	10.2%	17.2%
Return on assets	6.8%	7.0%	7.9%	6.4%	5.8%	4.7%	6.9%	13.0%	4.6%	8.1%
Current ratio	1.89	1.95	1.58	1.63	2.20	1.93	2.51	2.02	2.29	2.50
Debt to equity	0.71	0.66	0.70	0.79	0.84	1.07	0.87	0.84	0.72	0.72

Income statement

Income statement
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Revenue	$6.52B	$6.59B	$6.02B	$7.17B	$6.06B	$6.02B	$5.87B	$6.44B	$5.49B	$5.42B	$5.24B	$5.82B
Cost of revenue	$2.27B	$2.09B	$2.21B	$2.54B	$2.21B	$2.18B	$2.12B	$2.26B	$1.98B	$2.01B	$1.91B	$2.11B
Gross profit	$4.25B	$4.50B	$3.81B	$4.63B	$3.85B	$3.84B	$3.74B	$4.17B	$3.52B	$3.42B	$3.33B	$3.70B
Research and development	$433.00M	$434.00M	$413.00M	$401.00M	$410.00M	$407.00M	$405.00M	$358.00M	$377.00M	$363.00M	$368.00M	$350.00M
Selling, general and admin	$2.31B	$2.23B	$2.28B	$2.23B	$2.04B	$2.08B	$2.30B	$2.12B	$1.89B	$1.83B	$1.84B	$1.91B
Operating income	$1.03B	$1.66B	$936.00M	$1.80B	$1.14B	$1.11B	$837.00M	$581.00M	$1.08B	$1.05B	$972.00M	$1.26B
Interest expense	$143.00M	$141.00M	$148.00M	$154.00M	$157.00M	$159.00M	$137.00M	-	-	-	-	-
Pre-tax income	$997.00M	$1.56B	$850.00M	$1.71B	$1.03B	$1.02B	$764.00M	$528.00M	$1.04B	$998.00M	$923.00M	$1.23B
Income tax	$244.00M	$288.00M	$105.00M	$856.00M	$170.00M	$132.00M	$110.00M	-$18.00M	$209.00M	$173.00M	$135.00M	$83.00M
Net income	$753.00M	$1.28B	$745.00M	$849.00M	$859.00M	$884.00M	$654.00M	$546.00M	$834.00M	$825.00M	$788.00M	$1.14B
EPS, basic	$1.97	$3.32	$1.95	$2.21	$2.25	$2.32	$1.71	$1.43	$2.18	$2.17	$2.07	$3.01
EPS, diluted	$1.96	$3.30	$1.93	$2.20	$2.22	$2.29	$1.69	$1.41	$2.16	$2.14	$2.05	$2.98
Diluted shares	384.7M	386.0M	386.5M	-	386.7M	386.4M	386.4M	-	385.6M	385.4M	385.1M	-

Balance sheet

Balance sheet
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Cash and equivalents	$3.27B	$3.39B	$2.88B	$4.01B	$3.26B	$2.38B	$2.32B	$3.65B	$3.85B	$1.87B	$2.33B	$2.97B
Receivables	$3.69B	$3.74B	$3.57B	$4.04B	$3.64B	$3.92B	$3.96B	$3.99B	$3.74B	$3.62B	$3.47B	$3.77B
Inventory	$5.75B	$5.52B	$5.42B	$5.31B	$5.37B	$5.29B	$5.11B	$4.77B	$5.29B	$5.04B	$5.03B	$4.84B
Current assets	$14.18B	$14.42B	$13.34B	$14.76B	$13.71B	$13.00B	$13.02B	$14.85B	$14.67B	$11.64B	$11.89B	$12.52B
Goodwill	$19.33B	$19.58B	$19.19B	$19.29B	$19.26B	$19.18B	$19.09B	$15.86B	$16.40B	$15.41B	$15.35B	$15.24B
Total assets	$47.25B	$47.93B	$46.29B	$47.84B	$47.06B	$46.33B	$46.01B	$42.97B	$43.83B	$39.13B	$39.40B	$39.91B
Current liabilities	$6.50B	$6.68B	$6.32B	$7.79B	$7.41B	$7.29B	$7.93B	$7.62B	$7.67B	$6.93B	$6.96B	$7.92B
Short-term debt	$754.00M	$750.00M	$499.00M	$1.00B	$1.75B	$1.75B	$2.40B	$1.41B	$2.16B	$2.10B	$2.06B	$2.09B
Long-term debt	$14.18B	$14.19B	$14.22B	$14.86B	$14.85B	$14.83B	$14.38B	$12.19B	$13.32B	$10.13B	$10.81B	$10.90B
Total debt	$14.93B	$14.94B	$14.72B	$15.86B	$16.59B	$16.58B	$16.78B	$13.60B	$15.48B	$12.22B	$12.87B	$12.99B
Total liabilities	$23.79B	$23.94B	$23.31B	$25.42B	$25.27B	$25.14B	$25.08B	$22.34B	$23.68B	$19.37B	$20.23B	$21.32B
Shareholders' equity	$23.46B	$23.99B	$22.98B	$22.42B	$21.79B	$21.19B	$20.93B	$20.63B	$20.15B	$19.76B	$19.17B	$18.59B

Cash flow

Cash flow
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Operating cash flow	$1.46B	$1.26B	$581.00M	$2.14B	$1.54B	$1.11B	$250.00M	$1.93B	$1.47B	$633.00M	$204.00M	$1.53B
Capital expenditures	$237.00M	$202.00M	$166.00M	$268.00M	$187.00M	$183.00M	$123.00M	$266.00M	$170.00M	$152.00M	$167.00M	$145.00M
Free cash flow	$1.22B	$1.06B	$415.00M	$1.88B	$1.35B	$928.00M	$127.00M	$1.67B	$1.30B	$481.00M	$37.00M	$1.38B
Investing cash flow	-$187.00M	-$639.00M	-$185.00M	-$305.00M	-$321.00M	-$104.00M	-$4.14B	-$303.00M	-$2.17B	-$117.00M	-$408.00M	-$152.00M
Financing cash flow	-$1.39B	-$95.00M	-$1.51B	-$1.09B	-$339.00M	-$989.00M	$2.53B	-$1.79B	$2.65B	-$966.00M	-$418.00M	-$286.00M
Dividends paid	$338.00M	$337.00M	$337.00M	$321.00M	$322.00M	$321.00M	$320.00M	$305.00M	$305.00M	$305.00M	$304.00M	$285.00M
Stock-based compensation	$67.00M	$54.00M	$87.00M	$48.00M	$62.00M	$49.00M	$84.00M	$45.00M	$51.00M	$46.00M	$87.00M	$40.00M
Depreciation and amortization	$397.00M	$404.00M	$397.00M	$417.00M	$402.00M	$387.00M	$361.00M	$346.00M	$371.00M	$354.00M	$355.00M	-

Key ratios

Key ratios
Line item	Q3 2026 Sep 30, 2026	Q2 2026 Jun 30, 2026	Q1 2026 Mar 31, 2026	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024	Q4 2023 Dec 31, 2023
Revenue growth, YoY	7.6%	9.4%	2.6%	11.4%	10.2%	11.1%	11.9%	10.7%	11.9%	8.5%	9.7%	11.8%
Net income growth, YoY	-12.3%	44.3%	13.9%	55.5%	3.0%	7.2%	-17.0%	-52.2%	20.5%	11.8%	33.1%	103.0%
EPS growth, YoY	-11.7%	44.1%	14.2%	56.0%	2.8%	7.0%	-17.6%	-52.7%	20.0%	10.9%	33.1%	102.7%
Gross margin	65.2%	68.3%	63.3%	64.5%	63.6%	63.8%	63.8%	64.9%	64.0%	63.0%	63.6%	63.7%
Operating margin	15.9%	25.2%	15.5%	25.2%	18.7%	18.5%	14.3%	9.0%	19.7%	19.4%	18.5%	21.6%
Net margin	11.5%	19.4%	12.4%	11.8%	14.2%	14.7%	11.1%	8.5%	15.2%	15.2%	15.0%	19.7%
Free cash flow margin	18.8%	16.1%	6.9%	26.1%	22.3%	15.4%	2.2%	25.9%	23.7%	8.9%	0.7%	23.8%
Current ratio	2.18	2.16	2.11	1.89	1.85	1.78	1.64	1.95	1.91	1.68	1.71	1.58
Debt to equity	0.64	0.62	0.64	0.71	0.76	0.78	0.80	0.66	0.77	0.62	0.67	0.70

Source: XBRL data Stryker Corporation files with the SEC, latest filing dated Oct 30, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

Per-share figures are as filed. The filings show no stock split in these periods.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

SYK peers

Company	Revenue	Growth	Net income	Net margin	Market cap
SYK	$26.30B	+7.9%	$3.62B	13.8%	$121.36B
JNJJohnson & Johnson	$99.33B	+7.8%	$16.09B	16.2%	$675.03B
MDTMedtronic plc.	$37.54B	+9.8%	$5.24B	14.0%	$129.97B
BDXBecton Dickinson and Company	$23.25B	+17.4%	$941.00M	4.0%	$58.43B
ZBHZimmer Biomet Holdings Inc.	$8.57B	+7.0%	$767.30M	9.0%	$20.34B
BAXBaxter International Inc.	$11.61B	+5.3%	-$723.00M	-6.2%	$13.63B

SYK FAQ

9 questions

What is SYK revenue?
Stryker Corporation (SYK) reported $26.30B of revenue for the twelve months ended Sep 30, 2026. That is up 7.9% from the year before. Revenue for fiscal 2025 was $25.12B.
Is SYK profitable?
Yes. Stryker Corporation earned $3.62B in net income for the twelve months ended Sep 30, 2026, a net margin of 13.8%.
How much cash and debt does SYK have?
Stryker Corporation reported $3.27B in cash and cash equivalents and $14.93B of debt on its most recent balance sheet in SEC filings.
How fast is SYK revenue growing?
Stryker Corporation's revenue changed +11.2% in fiscal 2025, to $25.12B. Its compound annual growth rate was +11.8% over 5 years and +9.7% over 10 years.
What is SYK gross margin?
Stryker Corporation's gross profit was $17.18B on $26.30B of revenue for the twelve months ended Sep 30, 2026, a gross margin of 65.3%.
What is SYK free cash flow?
Stryker Corporation generated $4.57B of free cash flow for the twelve months ended Sep 30, 2026, which is operating cash flow of $5.45B less capital expenditures.
What is SYK earnings per share?
Diluted earnings per share were $9.39 for the twelve months ended Sep 30, 2026, from SEC filings, restated for any stock split those filings show.
When did SYK last report financial results?
The latest statements here come from Stryker Corporation's 10-Q filed on Oct 30, 2026, covering the period ended Sep 30, 2026.
Where does this SYK financial data come from?
Quantisnow builds these statements from the structured XBRL data Stryker Corporation files with the SEC. It is provided for information only and is not investment advice.